Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Net Cash Flow: 2017-2019

Historic Net Cash Flow for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to -$7.5 million.

  • Astria Therapeutics' Net Cash Flow fell 63.73% to -$7.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$5.0 million, marking a year-over-year decrease of 364.54%. This contributed to the annual value of -$115.9 million for FY2024, which is 174.75% down from last year.
  • As of Q4 2019, Astria Therapeutics' Net Cash Flow stood at -$7.5 million, which was down 192.05% from $8.2 million recorded in Q3 2019.
  • Over the past 5 years, Astria Therapeutics' Net Cash Flow peaked at $32.9 million during Q2 2018, and registered a low of -$30.1 million during Q3 2018.
  • Its 3-year average for Net Cash Flow is -$1.1 million, with a median of -$3.0 million in 2017.
  • Per our database at Business Quant, Astria Therapeutics' Net Cash Flow soared by 1,455.85% in 2018 and then plummeted by 650.98% in 2019.
  • Astria Therapeutics' Net Cash Flow (Quarterly) stood at -$5.3 million in 2017, then grew by 14.26% to -$4.6 million in 2018, then crashed by 63.73% to -$7.5 million in 2019.
  • Its last three reported values are -$7.5 million in Q4 2019, $8.2 million for Q3 2019, and -$2.0 million during Q2 2019.